Researcher at Lewis Katz School of Medicine at Temple University and Fox Chase Cancer Center Awarded $100,000 Grant From Mary Kay Ash Foundation for Breast Cancer Work

Dr. Boriello
Lucia Borriello, PhD, has been awarded a $100,000 Mary Kay Ash Foundation Innovative/Translational Cancer Research Grant.

PHILADELPHIA (October 26, 2023) — Lucia Borriello, PhD, an Assistant Professor in the Department of Cancer and Cellular Biology at the Lewis Katz School of Medicine at Temple University and a member of the Cancer Signaling and Microenvironment Research Program at Fox Chase Cancer Center, has been awarded a $100,000 Mary Kay Ash Foundation Innovative/Translational Cancer Research Grant.

“I feel humbled and honored to have been selected to receive this prestigious award, and I am delighted that my research is aligned with the mission of the Mary Kay Ash Foundation to eliminate breast cancers,” said Borriello. Her research focuses on understanding how the tumor microenvironment, which consists of normal cells in the immediate vicinity of cancer cells, promotes breast tumor dormancy and metastasis.

While more than 44,000 people in the United States die from breast cancer annually, most do not die due to the primary tumor, but because tumor cells spread to other organs such as the lungs where they form metastases. However, in most patients, tumor cells that migrate to the lung do not immediately begin growing, but can remain in a dormant state, sometimes for decades, before being triggered to grow and leading to metastasis.

The Mary Kay Ash Foundation grant will help Borriello explore how immune cells and macrophages promote breast tumor dormancy, with the goal of developing novel therapeutic strategies to eradicate dormant tumor cells and combat mortality from metastasis.

“For more than 25 years, the Mary Kay Ash Foundation has been unwavering in its mission to support cancer researchers who are seeking cures for cancers affecting women and provide life-saving resources to domestic violence shelters across the country,” said Michael Lunceford, President of the Mary Kay Ash Foundation Board of Directors. “These grants are just one of the ways we are continuing our mission to better the lives of women everywhere.”

Borriello was one of 12 cancer researchers to receive grants from the foundation in support of innovative/translational research efforts in cancers primarily affecting women, potentially leading to better detection, prognosis, and treatment options.

Borriello stressed that nothing ever comes from just one principal investigator. “This award reflects a unique and wonderful supportive and collaborative environment at Temple and Fox Chase. Absolutely, this award would not have been possible without the support of colleagues who are experts in the many disciplines needed to perform this complex project,” she said.

Over two decades, the Mary Kay Ash Foundation has awarded more than $92 million to cancer research programs, women’s shelters, and domestic violence service providers, as well as to related causes throughout the United States.

Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence six consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.

For more information, call 888-369-2427